| J0585 | Injection, onabotulinumtoxina, 1 unit | 8,500 | $10 | $42.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 600 | $60 | $33K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 230 | $90 | $19.2K |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | 2,450 | $1 | $9.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $120 | $7.1K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 90 | $70 | $5.8K |
| 64615 | The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the… | 40 | $100 | $3.8K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 50 | $80 | $3.7K |
| 64612 | In this procedure, the provider injects a chemical on one side of the face to disable the facial nerve and relieve painful facial nerve disorders or abnormal involuntary movements of facial muscles. | 30 | $120 | $3.7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 30 | $120 | $3.2K |